Abstract
Development of an effective human immunodeficiency virus (HIV) vaccine is one of the primary goals of global acquired immunodeficiency syndrome (AIDS) research. Despite progress in prevention of and powerful drug combinations to treat HIV infection, an estimated 16,000 people become infected every day. Over 90% of new infections occur in developing countries, in which recent medical advances are not immediately applicable or affordable. The best hope for these countries is the development of a safe, effective, accessible HIV vaccine. There is now growing optimism among scientists that an AIDS vaccine may be possible (1).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
